A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
Clinical trial NCT00566267 · COMPLETED
Trial details
- NCT number
- NCT00566267
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.